These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28404202)

  • 21. Enhancing the detection and management of acute hepatitis C virus infection.
    Martinello M; Matthews GV
    Int J Drug Policy; 2015 Oct; 26(10):899-910. PubMed ID: 26254495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus Therapy.
    Lazarus JV; Roel E; Elsharkawy AM
    Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.
    Salazar-Vizcaya L; Kouyos RD; Zahnd C; Wandeler G; Battegay M; Darling KE; Bernasconi E; Calmy A; Vernazza P; Furrer H; Egger M; Keiser O; Rauch A;
    Hepatology; 2016 Dec; 64(6):1856-1869. PubMed ID: 27531615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
    Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Dhersin JS; Yazdanpanah Y
    J Viral Hepat; 2015 Mar; 22(3):213-29. PubMed ID: 25270261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.
    Bouscaillou J; Champagnat J; Luhmann N; Avril E; Inaridze I; Miollany V; Labartkava K; Kirtadze I; Butsashvili M; Kamkamidze G; Pataut D
    Int J Drug Policy; 2014 Sep; 25(5):871-8. PubMed ID: 24529802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.
    Ruta S; Cernescu C
    World J Gastroenterol; 2015 Oct; 21(38):10811-23. PubMed ID: 26478672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.
    Bruggmann P
    J Viral Hepat; 2012 Dec; 19(12):829-35. PubMed ID: 23205675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus therapeutic development: in pursuit of "perfectovir".
    Dore GJ; Feld JJ
    Clin Infect Dis; 2015 Jun; 60(12):1829-36. PubMed ID: 25761867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
    Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Dhersin JS; Yazdanpanah Y
    Hepatology; 2016 Apr; 63(4):1090-101. PubMed ID: 26390137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
    Gvinjilia L; Nasrullah M; Sergeenko D; Tsertsvadze T; Kamkamidze G; Butsashvili M; Gamkrelidze A; Imnadze P; Kvaratskhelia V; Chkhartishvili N; Sharvadze L; Drobeniuc J; Hagan L; Ward JW; Morgan J; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1132-1135. PubMed ID: 27764081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New hepatitis C therapies: the toolbox, strategies, and challenges.
    Pawlotsky JM
    Gastroenterology; 2014 May; 146(5):1176-92. PubMed ID: 24631495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era.
    Chasser Y; Kim AY; Freudenreich O
    Psychosomatics; 2017; 58(1):1-10. PubMed ID: 27871760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The eradication of HCV.
    De Nicola S; Colombo M
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):63-75. PubMed ID: 26446686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is killing people with hepatitis C virus infection?
    Grebely J; Dore GJ
    Semin Liver Dis; 2011 Nov; 31(4):331-9. PubMed ID: 22189973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program.
    Butner JL; Gupta N; Fabian C; Henry S; Shi JM; Tetrault JM
    J Subst Abuse Treat; 2017 Apr; 75():49-53. PubMed ID: 28237054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.